Gainers

Südzucker (+7%): Benefits from a spectacular reversal by Barclays, which upgraded its recommendation from "sell" to "buy," hiking the price target from 9 EUR to 15 EUR. The German sugar producer convinced the British broker to radically shift its stance.

Alstom (+5%): Secured a 700 million euro systems contract in the AMECA region (Africa, Middle East, Central Asia), representing 30% of a total 2.75 billion USD project within a consortium. The French rail equipment manufacturer will book this order in the fourth quarter of its fiscal year, though the client's identity remains undisclosed.

SoftwareOne (+4%): Offset a dividend cut of nearly 50% (0.15 CHF vs. 0.27 CHF expected) with adjusted EBITDA surging 24% to 277 million CHF. The Swiss service provider is banking on operational performance to win over investors, targeting 5% growth and an EBITDA margin of 23% by 2026.

Getlink (+3%): In the spotlight as Mundy's considers increasing its stake from 15.5% to 25% of the capital without seeking control. The Channel Tunnel operator sees a second major shareholder strengthening its position after Eiffage (29.4%).

Edenred (+2%): Limits its decline despite JP Morgan trimming its price target from 35 EUR to 31 EUR while maintaining an "overweight" rating. The French prepaid service voucher specialist retains the American broker's confidence, with potential still viewed as positive.

Losers

Inventiva (-14%): The biopharmaceutical firm published disappointing results, marked by an annual net loss of 354.1 million EUR in 2025 compared to 184.2 million EUR in 2024. The operating loss also widened to 141 million EUR, exceeding the 97.6 million EUR loss from the previous fiscal year.

Clariant (-3%): After a week in the green, the specialty chemicals producer was hit by a research note from Goldman Sachs. The investment bank maintained its "sell" recommendation and reduced the price target from 8 to 7.50 CHF.

Dermapharm (-2%): Following a decline in revenue last year, the pharmaceutical manufacturer anticipates current-year revenues will fall short of expectations. This cautious outlook is also reflected in a downward revision of the dividend.

Aker (-2%): The oil exporter suffered a downgrade from Norne Securities AS, moving from "hold" to "sell." Despite raising the price target from 280 NOK to 320 NOK, the market reacted negatively to the change in recommendation.